Ugo Limbruno
Ugo Limbruno publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research and Cardiac Imaging and Diagnostics.
- World rank
- #1,246,559 of 7,710,434 ranked researchers
- Rank in Italy
- #39,808 of 242,206
- Works
- 288
- Citations
- 8.1k
- Citations per work
- 28.2
What does Ugo Limbruno research?
Ugo Limbruno's work is mostly in Medicine (74%), Engineering (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences21574.5%
- Medicine21574.5%
- Everything else6522.7%
- Physical Sciences82.8%
- Engineering82.8%
- 1Cardiology and Cardiovascular Medicine32% of their works
- 2Surgery21% of their works
- 3Radiology, Nuclear Medicine and Imaging10% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Epidemiology3% of their works
- 6Biomedical Engineering3% of their works
Research topics
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Peripheral Artery Disease Management
- Venous Thromboembolism Diagnosis and Management
Which keywords describe Ugo Limbruno's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Myocardial Infarction, Atherosclerosis, Guidelines, Coronary Stents, Myocardial Revascularization, Acute Coronary Syndromes and ST-Segment Elevation.
- Venous Thromboembolism
- Peripheral Arterial Disease
- Ventricular Tachycardia
- Clopidogrel
- Atrial Fibrillation
- Risk Factors
- Coronary Artery Disease
- ST-Segment Elevation
- Myocardial Revascularization
- Guidelines
- Myocardial Infarction
- Percutaneous Coronary Intervention
- Atherosclerosis
- Coronary Stents
- Acute Coronary Syndromes
- Cardiac Imaging
- Catheter Ablation
- Anticoagulant Therapy
- Aspirin
- Arrhythmias
- Angioplasty
- Antithrombotic Therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Percutaneous Coronary Intervention1232 topics
- Myocardial Infarction1172 topics
- Atherosclerosis1122 topics
- Guidelines1073 topics
- Coronary Stents941 topic
- Myocardial Revascularization941 topic
- Acute Coronary Syndromes591 topic
- ST-Segment Elevation591 topic
- Cardiac Imaging581 topic
- Coronary Artery Disease581 topic
- Catheter Ablation562 topics
- Risk Factors352 topics
- Anticoagulant Therapy301 topic
- Atrial Fibrillation301 topic
- Aspirin291 topic
- Clopidogrel291 topic
- Arrhythmias261 topic
- Ventricular Tachycardia261 topic
- Angioplasty181 topic
- Peripheral Arterial Disease181 topic
- Antithrombotic Therapy171 topic
- Venous Thromboembolism171 topic
Where does Ugo Limbruno work?
Ugo Limbruno's main affiliation in the publication record is Ospedale Misericordia - Grosseto, Italy.
How many publications and citations does Ugo Limbruno have?
OpenAlex counts 288 works and 8,122 citations for Ugo Limbruno, an h-index of 42, ranking #1,246,559 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ugo Limbruno. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.